{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:45:28Z","timestamp":1792986328220,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T00:00:00Z","timestamp":1641686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.radonc.2021.12.035","type":"journal-article","created":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T02:58:19Z","timestamp":1640746699000},"page":"211-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma \u2013 How safe are protons?"],"prefix":"10.1016","volume":"167","author":[{"given":"Semi B.","family":"Harrabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"von Nettelbladt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Gudden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Adeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Seidensaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Bahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mairani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Alber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Haberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Herfarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2021.12.035_b0005","first-page":"x1","article-title":"Alex's Lemonade stand foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011","volume":"16 Suppl","author":"Ostrom","year":"2015","journal-title":"Neurooncology"},{"key":"10.1016\/j.radonc.2021.12.035_b0010","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1468-1331.2010.03151.x","article-title":"Guidelines on management of low-grade gliomas: report of an EFNS\u2013EANO* Task Force","volume":"17","author":"Soffietti","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.radonc.2021.12.035_b0015","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00066-016-1005-9","volume":"192","author":"Harrabi","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2021.12.035_b0020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/cancers10110401","article-title":"Dosimetric comparison of proton radiation therapy, volumetric modulated arc therapy, and three-dimensional conformal radiotherapy based on intracranial tumor location","volume":"10","author":"Adeberg","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2021.12.035_b0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.addr.2016.11.006","article-title":"Proton therapy \u2013 Present and future","volume":"109","author":"Mohan","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.radonc.2021.12.035_b0030","doi-asserted-by":"crossref","first-page":"R419","DOI":"10.1088\/0031-9155\/59\/22\/R419","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer","volume":"59","author":"Paganetti","year":"2014","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2021.12.035_b0035","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1088\/0031-9155\/59\/16\/4635","article-title":"Integration and evaluation of automated Monte Carlo simulations in the clinical practice of scanned proton and carbon ion beam therapy","volume":"59","author":"Bauer","year":"2014","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2021.12.035_b0040","unstructured":"Ferrari, A., et al., FLUKA: A Multi-Particle Transport Code. 2005; SLAC National Accelerator Lab., Menlo Park, CA (United States). p. Medium: ED; Size: 405 pages."},{"key":"10.1016\/j.radonc.2021.12.035_b0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.nds.2014.07.049","article-title":"The FLUKA code: developments and challenges for high energy and medical applications","volume":"120","author":"B\u00f6hlen","year":"2014","journal-title":"Nucl Data Sheets"},{"key":"10.1016\/j.radonc.2021.12.035_b0050","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.radonc.2021.12.035_b0055","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1200\/JCO.2011.35.8598","article-title":"Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802","volume":"30","author":"Shaw","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.12.035_b0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0360-3016(96)00352-5","article-title":"A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) study 22844","volume":"36","author":"Karim","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.12.035_b0065","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(05)67070-5","article-title":"Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial","volume":"366","author":"van den Bent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2021.12.035_b0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.clineuro.2018.08.003","article-title":"Proton therapy for low-grade gliomas in adults: a systematic review","volume":"174","author":"Thurin","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.radonc.2021.12.035_b0075","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/cncr.29237","article-title":"Proton therapy for low-grade gliomas: results from a prospective trial","volume":"121","author":"Shih","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2021.12.035_b0080","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0360-3016(01)02692-X","article-title":"Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis","volume":"52","author":"Karim","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.12.035_b0085","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijrobp.2018.05.069","article-title":"Cognitive and adaptive outcomes after proton radiation for pediatric patients with brain tumors","volume":"102","author":"Pulsifer","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.12.035_b0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijrobp.2015.05.018","article-title":"Imaging changes in pediatric intracranial ependymoma patients treated with proton beam radiation therapy compared to intensity modulated radiation therapy","volume":"93","author":"Gunther","year":"2015","journal-title":"Int J of Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.12.035_b0095","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3109\/0284186X.2014.957414","article-title":"Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy","volume":"53","author":"Indelicato","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2021.12.035_b0100","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ijrobp.2017.11.037","article-title":"Radiation necrosis and white matter lesions in pediatric patients with brain tumors treated with pencil beam scanning proton therapy","volume":"100","author":"Bojaxhiu","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.12.035_b0105","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijrobp.2018.01.099","article-title":"Association of 1p\/19q codeletion and radiation necrosis in adult cranial gliomas after proton or photon therapy","volume":"101","author":"Acharya","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.12.035_b0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.radonc.2016.11.001","article-title":"Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma","volume":"121","author":"Peeler","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.12.035_b0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijrobp.2020.08.058","article-title":"Brain necrosis in adult patients after proton therapy: is there evidence for dependency on linear energy transfer?","volume":"109","author":"Niemierko","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.12.035_b0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.radonc.2021.08.015","article-title":"Study of relationship between dose, LET and the risk of brain necrosis after proton therapy for skull base tumors","volume":"163","author":"Garbacz","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.12.035_b0125","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijrobp.2009.02.091","article-title":"Radiation dose-volume effects in the brain","volume":"76","author":"Lawrence","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.12.035_b0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.12.035_b0135","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3174\/ajnr.A1362","article-title":"Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging","volume":"30","author":"Barajas","year":"2009","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.radonc.2021.12.035_b0140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11060-017-2545-2","article-title":"Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology","volume":"134","author":"Detsky","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2021.12.035_b0145","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2013.05.015","article-title":"Challenges with the diagnosis and treatment of cerebral radiation necrosis","volume":"87","author":"Chao","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.12.035_b0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11060-007-9341-3","article-title":"Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury","volume":"84","author":"Zeng","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2021.12.035_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00395","article-title":"Diagnosis and management of radiation necrosis in patients with brain metastases","volume":"8","author":"Vellayappan","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2021.12.035_b0160","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijrobp.2020.03.013","article-title":"Late contrast enhancing brain lesions in proton-treated patients with low-grade glioma: clinical evidence for increased periventricular sensitivity and variable RBE","volume":"107","author":"Bahn","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.12.035_b0165","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0360-3016(02)02754-2","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy","volume":"53","author":"Paganetti","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.12.035_b0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.radonc.2018.03.002","article-title":"Determination of the proton RBE in the rat spinal cord: Is there an increase towards the end of the spread-out Bragg peak?","volume":"128","author":"Saager","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.12.035_b0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2014.05.010","article-title":"Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment","volume":"90","author":"Chaudhary","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.12.035_b0180","doi-asserted-by":"crossref","first-page":"20160116","DOI":"10.1259\/bjr.20160116","article-title":"Why RBE must be a variable and not a constant in proton therapy","volume":"89","author":"Jones","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2021.12.035_b0185","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semradonc.2018.02.010","article-title":"Relative biological effectiveness uncertainties and implications for beam arrangements and dose constraints in proton therapy","volume":"28","author":"Paganetti","year":"2018","journal-title":"Seminars Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.12.035_b0190","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/mp.14739","article-title":"How can scanned proton beam treatment planning for low-grade glioma cope with increased distal RBE and locally increased radiosensitivity for late MR-detected brain lesions?","volume":"48","author":"Bauer","year":"2021","journal-title":"Med Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021090836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021090836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:21:53Z","timestamp":1759123313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814021090836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":38,"alternative-id":["S0167814021090836"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2021.12.035","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma \u2013 How safe are protons?","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2021.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}